These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38066859)

  • 1. Immunotherapy of acquired hemophilia A.
    Tiede A
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):19-23. PubMed ID: 38066859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A.
    Hart C; Klamroth R; Sachs UJ; Greil R; Knoebl P; Oldenburg J; Miesbach W; Pfrepper C; Trautmann-Grill K; Pekrul I; Holstein K; Eichler H; Weigt C; Schipp D; Werwitzke S; Tiede A
    J Thromb Haemost; 2024 Oct; 22(10):2692-2701. PubMed ID: 38936699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients.
    Lévesque H; Viallard JF; Houivet E; Bonnotte B; Voisin S; Le Cam-Duchez V; Maillot F; Lambert M; Liozon E; Hervier B; Fain O; Guillet B; Schmidt J; Luca LE; Ebbo M; Ferreira-Maldent N; Babuty A; Sailler L; Duffau P; Barbay V; Audia S; Benichou J; Graveleau J; Benhamou Y;
    Thromb Res; 2024 May; 237():79-87. PubMed ID: 38555718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should emicizumab be used in patients with acquired hemophilia A?
    Tiede A; Kemkes-Matthes B; Knöbl P
    J Thromb Haemost; 2021 Mar; 19(3):637-644. PubMed ID: 33306259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Hemophilia A: A Retrospective Multicenter Analysis of 42 Patients.
    Liu Y; Ruan X; Lei P; Shang B; Zhu Z; Chen S; Wang D; Wang R; Li X; Xue F
    Clin Appl Thromb Hemost; 2023; 29():10760296221151165. PubMed ID: 36653966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor eradication and treatment for acquired hemophilia A.
    Franchini M; Focosi D
    Expert Rev Hematol; 2024 Jun; 17(6):233-240. PubMed ID: 38708599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
    Collins P; Baudo F; Knoebl P; Lévesque H; Nemes L; Pellegrini F; Marco P; Tengborn L; Huth-Kühne A;
    Blood; 2012 Jul; 120(1):47-55. PubMed ID: 22517903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single-institution experience.
    Chen EC; Gibson W; Temoczko P; Connell NT; Handin R; Parnes AD
    Haemophilia; 2023 Jan; 29(1):84-89. PubMed ID: 36163651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International recommendations on the diagnosis and treatment of acquired hemophilia A.
    Tiede A; Collins P; Knoebl P; Teitel J; Kessler C; Shima M; Di Minno G; d'Oiron R; Salaj P; Jiménez-Yuste V; Huth-Kühne A; Giangrande P
    Haematologica; 2020 Jul; 105(7):1791-1801. PubMed ID: 32381574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of the clinical manifestations and efficacy of immunotherapy for patients with acquired hemophilia A.
    Gao F; Dong C; Du M; Li Z; Song Y; Li G
    J Int Med Res; 2024 Jul; 52(7):3000605241266221. PubMed ID: 39082241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acquired hemophilia A].
    Tokugawa T
    Rinsho Ketsueki; 2020; 61(7):785-790. PubMed ID: 32759566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of emicizumab in acquired hemophilia A: A case report.
    Yates SG; Webb CB; Sarode R; Ibrahim IF; Shen YP
    Transfus Apher Sci; 2022 Dec; 61(6):103457. PubMed ID: 35643753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired hemophilia A treated with rituximab in a 62-year-old female with rheumatoid arthritis: a case-based review.
    Mohamadzadeh D; Assar S; Farsad F
    Reumatismo; 2023 Dec; 75(4):. PubMed ID: 38115777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and Treatment Challenges for Acquired Hemophilia A in Pediatrics: Report of 2 Cases.
    Kim KS; Wong V; Thornburg CD; Yu JC
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1111-e1114. PubMed ID: 33181589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes in the treatment of acquired hemophilia A: a 16-year single institution prospective cohort experience.
    Loloi J; Moroi MK; Songdej N; Al-Mondhiry HA
    Blood Coagul Fibrinolysis; 2020 Jan; 31(1):43-47. PubMed ID: 31789659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired Hemophilia A: An Update on the Etiopathogenesis, Diagnosis, and Treatment.
    Zanon E
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Acquired Hemophilia A.
    Poston JN; Kruse-Jarres R
    Transfus Med Rev; 2022 Oct; 36(4):215-219. PubMed ID: 36280447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
    Tiede A; Hart C; Knöbl P; Greil R; Oldenburg J; Sachs UJ; Miesbach W; Pfrepper C; Trautmann-Grill K; Holstein K; Pilch J; Möhnle P; Schindler C; Weigt C; Schipp D; May M; Dobbelstein C; Pelzer FJ; Werwitzke S; Klamroth R
    Lancet Haematol; 2023 Nov; 10(11):e913-e921. PubMed ID: 37858328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emicizumab for the treatment of acquired hemophilia A.
    Knoebl P; Thaler J; Jilma P; Quehenberger P; Gleixner K; Sperr WR
    Blood; 2021 Jan; 137(3):410-419. PubMed ID: 32766881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.